Herikîn Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Herikîn General Information
Description
Developer of RNA manufacturing technology designed to automate and scale mRNA production processes. The company's platform offers modular hardware systems, continuous-flow fluidics and integrated biological processing, enabling pharmaceutical developers, researchers and agricultural producers to produce RNA efficiently for therapeutics, research and crop applications.
Contact Information
Website
www.herikin.comCorporate Office
- Australia
Corporate Office
- Australia
Herikîn Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-May-2025 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 14-Oct-2024 | Completed | Generating Revenue |
Herikîn Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Radar Ventures (Australia) | Venture Capital | Minority | ||
| UNSW Founders | Accelerator/Incubator |
Herikîn FAQs
-
Where is Herikîn headquartered?
Herikîn is headquartered in Australia.
-
What industry is Herikîn in?
Herikîn’s primary industry is Biotechnology.
-
Is Herikîn a private or public company?
Herikîn is a Private company.
-
What is Herikîn’s current revenue?
The current revenue for Herikîn is .
-
Who are Herikîn’s investors?
Radar Ventures (Australia) and UNSW Founders have invested in Herikîn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process